Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Elevai Labs, Inc. - Common Stock (NQ: ELAB ) 0.0189 +0.0010 (+5.59%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Elevai Labs, Inc. - Common Stock < Previous 1 2 3 Next > Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Encouraging Data Results Indicating Potential for Hair Restoration Using Proprietary Exosome Technology September 03, 2024 From Elevai Labs Inc. Via GlobeNewswire 12 Consumer Staples Stocks Moving In Monday's After-Market Session September 02, 2024 Via Benzinga Elevai Labs Inc. Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Care Technology Utilizing YuvaBioⓇ Y100™ Mitochondrial Innovation and Elevai Exosomes™ August 28, 2024 From Elevai Labs Inc. Via GlobeNewswire ELAB Stock Earnings: Elevai Labs Reported Results for Q2 2024 August 14, 2024 Elevai Labs just reported results for the second quarter of 2024. Via InvestorPlace ELAB Stock Earnings: Elevai Labs Reported Results for Q1 2024 May 15, 2024 Elevai Labs just reported results for the first quarter of 2024. Via InvestorPlace Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Data Results with Completion of Clinical Study of Elevai Enfinity™ Topical Exosome Serum August 26, 2024 From Elevai Labs Inc. Via GlobeNewswire Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket August 26, 2024 Via Benzinga Why Workday Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket August 23, 2024 Via Benzinga ELAB Stock Earnings: Elevai Labs Reported Results for Q4 2023 April 02, 2024 Elevai Labs just reported results for the fourth quarter of 2023. Via InvestorPlace Elevai Labs Inc. Subsidiary, Elevai Research Inc., Announces Preliminary Positive Research Data Highlighting the Potential of Proprietary Exosome Technology for Skin Health Applications August 19, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update August 14, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs Inc. Subsidiary, Elevai Biosciences, Continues to Advance its Scientific Advisory Board with the Appointment of Orian Shirihai, MD, PhD July 30, 2024 From Elevai Labs Inc. Via GlobeNewswire Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket July 25, 2024 Via Benzinga Top 4 Risk Off Stocks You'll Regret Missing In July July 16, 2024 Via Benzinga Elevai Labs Inc. Subsidiary, Elevai Skincare, Announces The Elevai S-Series Hair and Scalp Care Product Line June 28, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs Inc. Subsidiary, Elevai Skincare to Debut Upcoming New Product Line at The Aesthetic Show 2024 June 26, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs June 14, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs Subsidiary, Elevai Skincare, to Present at the Beauty Through Science Conference in Stockholm May 29, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs Inc Subsidiary, Elevai Biosciences, to Present at the UCLA LA-BEST 2024 Conference May 22, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs (NASDAQ: ELAB) Acquires Rights To Develop Muscle Loss Prevention Assets For Anticipated Use In Anti-Obesity Treatments, Launches Two New Subsidiaries May 17, 2024 Elevai Labs (NASDAQ: ELAB) Acquires Rights To Develop Muscle Loss Prevention Assets For Anticipated Use In Anti-Obesity Treatments, Launches Two New Subsidiaries Via News Direct Elevai Labs Inc. Reports First Quarter 2024 Financial Results May 15, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity May 02, 2024 From Elevai Labs Inc. Via GlobeNewswire 12 Consumer Staples Stocks Moving In Wednesday's After-Market Session May 01, 2024 Via Benzinga Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare May 01, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments May 01, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line Revenue Commitments April 29, 2024 From Elevai Labs Inc. Via GlobeNewswire ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months April 22, 2024 From Elevai Labs Inc. Via GlobeNewswire 12 Consumer Staples Stocks Moving In Tuesday's After-Market Session April 09, 2024 Via Benzinga Elevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial Results March 29, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market March 18, 2024 ELEVAI Physician-Dispensed Skincare Now Available Direct to Consumers From Elevai Labs Inc. Via GlobeNewswire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
